Coronary embolism in left-sided infective endocarditis. A retrospective analysis from a high-volume surgical centre and review of the literature Authors: Ruggero Mazzotta, Matteo Orlandi, Valentina Scheggi, Niccolò Marchionni, Pierluigi Stefàno, Ahmed Qasim Mohammed Alhatemi, Ahmed Qasim Mohammed Alhatemi, Ahmed Qasim Mohammed Alhatemi Published: 2024 ABSTRACT BackgroundSeptic embolization is a common and potentially life-threatening complication of infective endocarditis (IE), with a prevalence of 22–50%. While acute coronary syndrome secondary to septic embolism is rare, it poses significant risks.AimsThis study examines coronary embolism (CE) in left-sided IE, describing clinical characteristics and outcomes.MethodsWe retrospectively analysed 649 patients with non-device-related left-sided IE treated between January 2013 and December 2023 in a high-volume surgical centre. CE was diagnosed via ECG, clinical and laboratory signs of acute coronary syndrome, and confirmed by coronary angiography or magnetic resonance imaging. All patients were treated according to current European Society of Cardiology guidelines. A structured follow-up was performed.ResultsAmong patients included in the study, surgery was performed in 514 (79%) patients. Median follow-up duration was 4.7 years. CE occurred in 8 (1.2%) patients, and 6 (80%) of them were treated surgically. We found no significant differences in overall mortality rate between patients with or without CE (p = 0.65). Finally, cerebral embolism was significantly more frequent in patients with than without CE (75% vs 25%, p = 0.006, post-hoc power 87.8%).ConclusionCE is a rare but severe complication of IE, significantly associated with cerebral embolism. Early recognition and treatment are crucial to improve patient outcomes. Multicentre studies with larger patient populations are needed to further elucidate risk factors and enhance prognosis for CE in IE patients. Introduction Septic embolization is a frequent and potentially life-threatening complication of infective endocarditis (IE) [1, 2]. Embolic risk is high among patient diagnosed with IE, with a prevalence of 22–50%, and most emboli involve the central nervous system [3]. Acute coronary syndrome (ACS) secondary to septic embolism is rare and has been addressed by few studies, the oldest ones reporting coronary arteries microemboli in more than 60% of post-mortem examinations [4, 5]. ACS in the setting of IE may not only be secondary to coronary embolism (CE). In fact, several studies found that the most common cause of ACS during IE is compression of a coronary artery by periaortic pseudoaneurysm or abscess [6–10]. Other less common mechanisms include obstruction of the coronary ostium by a large vegetation, especially in case of fungal endocarditis, [11] coexistent coronary artery disease that emerges clinically during the infection due to anaemia, fever, and activation of the coagulation system, and the occurrence of severe aortic valve regurgitation, which can per se cause myocardial ischemia because of reduced coronary perfusion pressure [6]. Methods Patient selection We retrospectively analysed 649 consecutive patients with non-device-related left-sided IE admitted to our high-volume surgical centre between January 2013 and December 2023. The study was approved by the local ethics Committee that, in keeping with statements by the Italian Regulatory Authorities for retrospective, observational studies, [12] granted a waiver of informed consent from study participants. Data collection took place between January 2019 and July 2024. Data for analysis were obtained from electronic hospital charts, anonymized, and protected by password. CE was diagnosed by ECG, clinical and laboratory signs of ACS and confirmed by coronary angiography or magnetic resonance imaging (MRI). Diagnostic work-up We followed current European Society of Cardiology guidelines for diagnostic work-up and treatment strategies [13]. Accordingly, three sets of blood cultures were collected on admission and transoesophageal echocardiography (TEE) was performed in all patients for diagnosis confirmation. Systemic embolism was sought clinically and radiologically by brain and chest computed tomography (CT) plus abdominal CT or ultrasound scan. All patients were treated with empirical and, whenever feasible, targeted antimicrobial therapy. Surgical indication and operative technique An Endocarditis Team including a cardiac surgeon, a cardiologist, an anaesthesiologist, an internist, a neurologist and an infectious disease specialist evaluated each patient. Surgical risk was estimated by EuroSCORE II [14]. Surgery was advised according to current European Society of Cardiology guidelines [13]. Follow-up and study endpoints The duration of follow-up was calculated from the time of IE diagnosis. A structured phone interview was implemented to update the follow-up to December 2023. Our primary objective was describing clinical characteristics and the outcome of patients with CE. Statistical analysis The chi-square and the Mann-Whitney or Kruskal-Wallis tests were used to compare respectively proportions and continuous variables with normal or non-normal distribution. The Kaplan-Meier method was used to estimate the survival probability. All tests were 2-sided, and statistical significance was defined as a p value <0.05. All analyses were performed with SPSS software version 24.0 (IBM Corp., Armonk, New York). Results The demographic, echocardiographic, clinical and microbiological characteristics of the 649 patients are shown in Table 1. Surgery was not indicated in 68 (10%) out of 649 patients, whereas 67 (10%) were not operated because of prohibitive surgical risk; the remaining 514 (80%) underwent surgical valve repair (n = 93, 18%) or replacement (n = 421, 82%). The median follow-up duration was 4.7 years. CE occurred in 8 (1.2%) patients. The main clinical characteristics of the 8 patients with CE are summarized in Table 2. 6 patients (80%) with CE were treated surgically. We found no significant differences in overall mortality rate between patients with or without CE (p = 0.65). Three-year all-cause mortality rate of the whole cohort was 35%. Despite the small sample of CE patients, we found a statistically significant association of coronary and cerebral embolism, with a post-hoc power of 87.8%. All statistical analyses were limited by the small sample of CE patients. 10.1371/journal.pone.0314718.t001Table 1Demographic, echocardiographic, clinical and microbiological characteristics of 649 patients with left-sided infective endocarditis by the occurrence of coronary embolism.Coronary embolismp-valueNo(n = 641)Yes(n = 8)Age, years, mean ± SD67.0 ± 14.053.3 ± 23.80.05Female sex, n (%)220 (34.3)2 (25.0)0.58BMI, mean ± SD24.8 ± 4.323.6 ± 4.00.7Chronic kidney disease, n (%)151 (23.6)3 (37.5)0.35Diabetes, n (%)136 (21.2)0 (0)0.14Hypertension, n (%)403 (62.9)2 (25.0)0.058Dyslipidaemia, n (%)198 (30.9)1 (12.5)0.22Intravenous drug abuse, n (%)40 (6.2)0 (0)0.46Native valve, n (%)389 (60.7)3 (37.5)0.18Aortic valve IE, n (%)362 (56.5)5 (62.5)0.86Perivalvular extension, n (%)133 (20.7)3 (37.5)0.24Severe valvular dysfunction, n (%)323 (50.4)3 (37.5)0.47Vegetation length, mm, mean ± SD8.8 ± 7.48.8 ± 7.70.47LVEF, %, mean ± SD56.5 ± 9.753.5 ± 12.00.58EuroSCORE II log, mean ± SD13.1 ± 16.513.92 ± 9.70.65Surgery, n (%)507 (79.1)7 (87.5)0.62Cerebral embolism, n (%)168 (26.2)6 (75.0)0.006Abdominal embolism, n (%)85 (13.3)1 (12.5)0.95Spondylodiscitis, n (%)51 (8.0)0 (0)0.4Germ, n (%):0.92 • Streptococci155 (24.2)1 (12.5) • Staphylococci180 (28.1)2 (25.0) • Enterococci133 (20.7)2 (25.0) • Other50 (7.8)1 (12.5) • Negative culture122 (19.0)2 (25.0)IE = infective endocarditis; BMI = body mass index; LVEF = left ventricular ejection fraction. Demographic, echocardiographic, clinical and microbiological characteristics of 649 patients with left-sided infective endocarditis by the occurrence of coronary embolism. IE = infective endocarditis; BMI = body mass index; LVEF = left ventricular ejection fraction. 10.1371/journal.pone.0314718.t002Table 2Summary of main characteristics of 8 patients with infective endocarditis and coronary embolism.Case #Age (years)ValveVegetation length (mm), if presentSite of CE, if knownNative/prosthetic valveGerm typeSurgeryDeath152Aortic-LCx arteryBiologicStaphylococcus lugdunensisYesNo287Mitral14LAD arteryNativeNegative cultureYesNo333Aortic10-NativeGemella morbillorumYesNo476Mitral20Diagonal branchBiologicEnterococcus faecalisYesYes577Aortic12RCABiologicEnterococcus faecalisYesNo643Mitral6LAD artery and OM branchNativeStaphylococcus aureusYesNo732Aortic-RCABiologicListeria monocytogenesExcludedYes825Aortic14-MechanicalNegative cultureYesNoLCx = left circumflex; LAD = left anterior descending; RCA = right coronary artery; OM = obtuse marginal. Summary of main characteristics of 8 patients with infective endocarditis and coronary embolism. LCx = left circumflex; LAD = left anterior descending; RCA = right coronary artery; OM = obtuse marginal. Clinical presentation and treatment of the 8 patients with CE Case 1 A 52-year-old man presented to the emergency department complaining fever (38.5°C) and myalgias for one week. His past medical history reported a Bentall operation with implantation of a biologic prosthetic valve 14 years before. Shortly after hospital admission, he had typical chest pain: the ECG showed inferior ST-elevation. Transthoracic echocardiography revealed left ventricular inferior apical akinesia and a non-echogenic image suggestive of a periaortic abscess. Immediate coronary angiography revealed an embolic occlusion of mid-distal left circumflex artery, treated with thromboaspiration (Fig 1). Empirical antibiotic therapy with vancomycin, gentamicin and rifampicin was started. Blood cultures tested positive for Staphylococcus lugdunensis, and antimicrobial therapy was switched to oxacillin. The patient underwent redo Bentall surgery with a mechanical prosthetic valve. The postoperative course was uneventful and at discharge the aortic prosthesis was well-functioning. Embolic occlusion of left circumflex artery (a) and final angiographic result after thromboaspiration (b) in a patient with infective endocarditis. Case 2 An 87-year-old woman was admitted to the emergency department for typical chest pain, fever (37.9°C) and general malaise. An ECG showed an inferior and lateral ST-elevation. At coronary angiography, there was an embolic occlusion of distal left anterior descending artery. No interventional procedure was performed. The patient underwent TEE with evidence of severe calcific mitral valve stenosis associated with moderate regurgitation and findings suggestive of anterior leaflet vegetations. Blood cultures were negative. Empirical antibiotic therapy (amoxicillin/clavulanate and gentamicin) was started. During her hospital stay, the patient complained of dizziness and paraesthesia of the right upper limb. Therefore, brain CT and MRI were performed and showed multiple acute ischemic lesions, the largest located in the left occipital region. She was promptly operated of mitral valve replacement with a biological prosthesis, progressively improved over the next two weeks, and she was finally discharged after in-hospital cardiac rehabilitation. Case 3 A 33-year-old man complained of dyspnoea, asthenia, and fever for about one month. Prior to hospital admission, a chest X-ray and CT scan had resulted negative and fever, but not dyspnoea, had been resolved after empirical antibiotic therapy. He therefore went to a cardiologist who diagnosed severe aortic regurgitation with suspected infective vegetations of aortic valve. Left ventricular distal inferior akinesia was also noted. He was then sent to hospital where a TEE and positron emission tomography confirmed IE of aortic valve. The ECG was normal. The diagnostic workup was completed with a cardiac MRI, showing a moderately dilated left ventricle with distal inferior focal necrosis strongly suggestive of septic embolization. Empirical antibiotic therapy with vancomycin and ceftriaxone was started. Blood cultures were positive for Gemella morbillorum. Surgical aortic valve replacement with a biological prosthesis was deemed indicated and the patient was discharged one week later to a cardiologic rehabilitation unit. Case 4 A 76-year-old man who had been operated of surgical mitral valve replacement with a biological prosthesis one year before, was admitted to the emergency department because of paroxysmal nocturnal dyspnoea and abdominal pain for about three days. At blood tests, inflammation markers and D-dimer were elevated. Prompt CT angiography excluded a pulmonary embolism but found a focal splenic embolization. Transthoracic echocardiography and subsequent TEE showed degenerated mitral prosthesis with severe stenosis and mild regurgitation, and vegetations consistent with IE. Antibiotic therapy with ceftriaxone and daptomycin was started. Blood cultures tested positive for Enterococcus faecalis. Routine coronary angiography prior to cardiac surgery found an embolic occlusion of first diagonal branch, treated with thromboaspiration. A few hours later he manifested dysarthria, after which a cranial CT scan showed left temporal and parietal hypodense areas. Clinical conditions rapidly deteriorated and the patient underwent urgent redo mitral valve replacement with a biological prosthesis. The postoperative course was complicated by hemodynamic instability, requiring prolonged treatment with inotropes and vasopressors, and worsening respiratory failure. He died a few weeks later of multi-organ failure. Case 5 A 77-year-old man presented to the emergency department with fever, asthenia, and diffuse thoraco-abdominal pain from one month. 8 years before he had been operated of Bentall procedure due to acute post-traumatic aortic dissection. The ECG showed inferior ST-elevation, and prompt coronary angiography found ostial occlusion of right coronary artery. TEE demonstrated IE vegetations on the aortic valve prosthesis. Empirical antibiotic therapy with daptomycin, gentamycin, and rifampicin was started. A cranial CT revealed an extended right occipital-mesial hypodense area. Blood cultures tested positive for Enterococcus faecalis. The patient underwent redo Bentall operation with a biologic prosthesis and coronary artery bypass graft. Case 6 A 43-year-old man with hyperthyroidism and severe hyperbilirubinemia secondary to methimazole toxicity, was repeatedly treated with plasmapheresis via a femoral line. After one week the patient complained of fever and myalgias. Blood cultures and culture exam of the tip of the femoral central line tested positive for methicillin-sensible Staphylococcus aureus. Antibiotic therapy with vancomycin and gentamycin was started. After a few days the patient had typical chest pain. The ECG displayed an inferior and posterior ST-elevation myocardial infarction. Immediate coronary angiography showed embolic obstruction of the first obtuse marginal branch, treated with mechanical embolectomy and balloon angioplasty. Culture exam of embolic material tested positive for gram-positive cocci. TTE and TEE demonstrated an IE vegetation on the mitral valve with moderate regurgitation (Fig 2), while a full-body CT scan showed findings of brain micro-embolism. The patient was operated of mitral valve repair with excision of the IE vegetation. The post-operative course was initially complicated by transient hemodynamic instability. At discharge, transthoracic echocardiography showed a well-functioning mitral valve with no residual mitral regurgitation. Endocarditic vegetation on the mitral valve. Case 7 A 32-year-old woman with a history of rheumatic heart disease treated 2 years before with aortic and mitral valve replacement with biological prostheses, was admitted to the hospital due to fever, worsening arthro-myalgias, and purpura of the lower limbs. Blood cultures tested positive for Listeria monocytogenes, so antibiotic therapy with meropenem, trimethoprim/sulfamethoxazole and levofloxacin was started. A full-body CT scan displayed an area of detachment at the level of the aortic valve prosthesis with a voluminous periaortic abscess and an ostial obstruction of the right coronary artery. TEE confirmed those findings and, therefore, redo aortic valve surgery was planned. While waiting for surgery, the patient suddenly had right hemiplegia and global aphasia, with CT finding of a large hematoma secondary to ruptured mycotic pseudoaneurysm of the right middle cerebral artery, treated endovascularly (Fig 3). A few days later, she underwent surgical drainage of the intraparenchymal hematoma. Repeated TEE showed mild reduction of the periaortic abscess. Cardiac surgery was therefore deferred, and the patient was transferred to a rehabilitation centre where she suddenly complained of chest pain. The ECG displayed inferior ST- elevation and lateral ST-depression, with echocardiographic findings of interventricular septum and left ventricular inferior wall dyskinesias. Prompt coronary angiography was performed, but after cannulating the left coronary artery the patient had refractory cardiopulmonary arrest and died before the coronary arteries could be visualized. Brain CT scan showing a large intraparenchimal hematoma (left) in a patient with angiographical demonstration of ruptured pseudoaneurysm of the right middle cerebral artery (right). Case 8 A 25-year-old man who had been operated one year before of aortic valve replacement with a mechanical prosthesis for aortic bicuspidia, presented to the emergency department after the sudden onset of typical chest pain following a one-week complain of fever and asthenia, and transient dysarthria. The ECG showed hyperacute T waves and diffuse ST-elevation, more pronounced in the lateral leads. Transthoracic echocardiography and subsequent TEE displayed a well-functioning aortic prosthesis, but with an adherent mobile formation on a leaflet. Patient’s adherence to oral warfarin was proven by in-range INR values. Blood cultures tested negative. Empirical antibiotic therapy with daptomycin, gentamycin and rifampicin was started. Coronary CT angiography was completely negative, whereas cardiac MRI detected recent transmural infarcted segments in the middle septum and apex, strongly suggestive of microvascular embolization. In the following days, the patient experimented transient dysarthria and diplopia, with MRI finding of multiple embolic lesions of the brain. He underwent urgent cardiac surgery with positioning of an aortic homograft sutured to a Dacron vascular prosthesis. The patient recovered well from surgery without no major complications and at discharge the aortic homograft was well-functioning. Discussion Septic CE is an infrequent, yet recognized, cause of type 2 myocardial infarction [15]. Nevertheless, this event represents a serious complication of IE, with high mortality rates. Cases of CE during nonbacterial endocarditis have also been described [16, 17]. Three studies with more than 500 patients have shown a prevalence of CE in IE of 0.31–0.51% among all cases and of 1.5–3.5% among patients with embolic events. [6, 18, 19] In the setting of ACS without a history of obstructive coronary artery disease, CE must be suspected in the presence of a prosthetic valve associated with fever [6, 20]. Prosthetic valve IE represents one of the major downsides of valvular heart surgery and accounts for 20% of all cases of IE [21]. Staphylococcus aureus is currently the most common cause of prosthetic valve IE [22]. Staphylococcus lugdunensis affects mostly native valves and has an aggressive course; in prosthetic valve IE, it is usually localized in the aortic position and associated with abscess formation and poor prognosis [23]. Perivalvular abscess formation is associated with a more aggressive course and worst outcomes; it is more commonly seen as a complication of prosthetic valve IE, especially aortic, and appears to occur more often in IE caused by Staphylococcus aureus [24, 25]. Systemic embolization is one of the most dreaded complications of IE, occurring in 22–50% of cases [2, 26]. Brain, spleen and kidney are the most frequent sites of embolism for left-sided IE, while pulmonary embolism is frequent in right-sided IE. Stroke may be the first clinical manifestation of IE and represents a complication associated with increased mortality and morbidity [1, 2, 27]. Studies investigating specific risk factors for CE are scarce [28]. A study showed that CE was most commonly seen in patients with aortic valve endocarditis, and this may be explained by the proximity of aortic vegetations to the coronary ostia [29]. CE is most often secondary to arterial thromboembolism, mainly in the setting of atrial fibrillation; septic emboli are less frequent, complicating <1% of IE [25, 30, 31]. ACS as a complication of IE can also occur due to compression of the coronary artery ostia by an aortic root abscess [30, 32]. Presence of prosthetic valve, a new precordial murmur, fever and leucocytosis are all factors compatible with CE as the potential cause of ACS but are not enough to exclude a priori atherosclerotic cardiovascular disease [33]. CE is most frequent in the left anterior descending artery, due a facilitating anatomy [33, 34–36]. In a study by Nazir et al, who described 100 patients with ST-elevation myocardial infarction associated with IE reported by 95 articles, embolic events occurred mainly in the left coronary branches (87% of cases: 75% involving the left anterior descending artery, 10% the left circumflex artery, 2% the left main) while the right coronary artery was the culprit vessel in the remaining cases [32]. Embolization of the left circumflex artery, as described in our #1 and #5 cases, is therefore an atypical clinical scenario. Besides the management of possible complications, the treatment mainstay of IE remains appropriate antibiotic therapy and surgery. Treatment of CE secondary to IE is challenging. Embolectomy, balloon angioplasty, and stent placement may be required [37, 38]. Aspiration and/or mechanical thrombectomy has been advocated as a reasonable first-line choice in this context, particularly considering the risks of angioplasty and stenting of an infected thrombus [32, 39–42]. In fact, stent placement in septic CE cases is still debated due to the risk of dilation site, mycotic aneurysm formation and rupture, and distal embolization [20, 37, 43]. Yet, mycotic aneurysm formation may be a serious complication of balloon angioplasty too, due to potential intimal disruption and secondary bacterial seeding [44, 45]. Indeed, in our case series balloon angioplasty was deemed to be necessary in only one case, and in no case a stent was placed to optimize results obtained with aspiration or mechanical thrombectomy. Lastly, there is an absolute contraindication to fibrinolytic therapy in the setting of IE due to a high-risk of intracranial haemorrhage [46, 47]. Since evidence of ACS complicating IE is derived mainly from case reports, uncertainty remains regarding the best treatment strategy. In conclusion, an early invasive catheter-intervention appears a feasible option, while conservative, or multi-step, management is associated with worst outcomes, [20, 32, 33, 36, 48, 49] as demonstrated by our #7 case. Our retrospective analysis of 649 patients with IE has demonstrated a 1.2% prevalence of CE. We have found a statistically significant association between coronary and cerebral embolism, with a post-hoc power of 88.1%. Given the rarity of CE, no other statistically significant difference in either baseline characteristics or mortality rates was found. To the best of our knowledge, the association rate between CE and cerebral embolism in patients with IE has never been described in the literature. Therefore, septic cerebral embolism could represent a risk factor for CE. The typical clinical presentation of CE during IE is ACS with chest pain, ECG changes and troponin elevation. However, in case #3 and #4, CE has passed asymptomatically. In case #3, the diagnosis was made by MRI. In case #4, coronary angiography was performed as routine before cardiac surgery, and the finding of CE was incidental. Of the 8 patients with CE, 3 were treated with thromboaspiration and 7 underwent cardiac surgery (see Table 2). In our case study, two patients’ blood cultures were negative, and two patients tested positive for Enterococcus faecalis (see Table 2). No other specific microorganism was prevalent. These findings are likely attributable to the low number of patients with CE in our population. Vegetation length was greater than 1 cm in 5 of our 8 patients with CE, which may explain the high tendency of these vegetations to embolize (see Table 1). Of the 8 patients with CE, 5 had aortic valve and 3 had mitral valve IE. Only one patient had a mechanical prosthetic valve, 4 had a biologic prosthetic valve and 3 had no prosthesis (see Table 2). The coronary involvement was heterogeneous. Two patients (25%) died close to the infectious and embolic events. This finding might suggest how IE complicated by CE represents a serious clinical condition with high morbidity and mortality that should be promptly recognized and treated. Last but not least, it is important to emphasize how aggressive surgical management of complicated IE can improve patients’ prognosis. In fact, it has been demonstrated that conservative approach was associated with an adverse prognosis [50]. It has also been found that vegetations with a length > 10 mm increases the risk of embolic events [51]; early surgical treatment could therefore avert these serious complications. Conclusion CE is a rare and serious complication of IE. In our case series, we have found a significant association between CE and cerebral embolism. There were no association with the presence of native or prosthetic valve. The mortality rate was high (25%). Due to the low prevalence, multicentre studies including larger numbers of patients are needed to be able to identify risk factors of CE in IE that will help in the early recognition of this condition so that clinicians can have a crucial impact in improving their patients’ prognosis. Limitations Our study has several limitations. The number of patients with IE and CE is small and the cases included in this study are drawn from a single centre, therefore this limits the ability to generalize findings. Multicentre studies are therefore needed to confirm our results. The number of patients with CE could be higher than what we reported. In fact, besides symptomatic patients or patients with ECG, echocardiographic or MRI signs of myocardial ischemia or infarction, only patients with IE and an indication to surgery underwent coronary angiography. Thus, patients with IE and not candidates for surgery could have developed CE that passed asymptomatic. 16 Oct 2024 PONE-D-24-38850Coronary embolism in left-sided infective endocarditis. A retrospective analysis from a high-volume surgical centre and review of the literaturePLOS ONE Dear Dr. Orlandi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ==============================Dear authors, I'm pleased to inform you that your manuscript has been reviewed, and I believe it has great potential.The reviewers have provided insightful comments and suggestions. Please address these minor revisions to enhance the quality of your paper. I am confident that your responses will significantly strengthen your work. Please submit your revised manuscript by Nov 30 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ahmed Qasim Mohammed Alhatemi Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Embolic events in infective endocarditis remain a major concern affects management. 1. Being a retrospective review, is there any chance that some coronary embolization were not diagnosed because they did not result in clear ACS? was there any biomarker data that may shed more light on this point? 2. How systematic was the search for cerebral embolization, again could many cerebral emboli have been missed? 3.The cases document when the coronary events occurred and I think it would be useful to include the time from presentation to the occurrence of coronary embolism in hours and also the duration of antibiotic therapy in tables 1 and 2 to see if embolic events represent delays in initiating antimicrobial therapy in relation to the diagnosis of possible infective endocarditis and try to understand better the predictors of coronary embolization. 4. It is not clear from the manuscript whether vegetation length was by 2D or 3 D. This needs to be clarified. 5. Also I did not see any specific analysis for Coronary Embolization related to the mitral valve. 6. Is there any other echo parameter of the vegetation that can be related to cerebral or coronary embolization. Answers to all the above points should be incorporated into the manuscript so that readers may benefit more from this case series. 7. A limitation section need to be included. Reviewer #2: Thank you for this case series. I would like the authors to clarify how they decided to deal with the coronary emboli. In some cases, they left it alone and in some cases, they intervened. On what basis was the decision made? I also want to know if they analysed the recovered embolic material and identified the causative pathogen, especially in culture negative cases. Finally, in case no.3, the authors state that the empirical antibiotics used were vancomycin and ceftriaxone, this is not a regular combination, why was it used? Reviewer #3: The authors presented a compilation of rare cases coronary embolism caused by infective endocarditis. The clinical history of each case was also summarised well. This is not an easy task to collect these types of rare cases. The efforts by the author should be commended. The possible association between coronary embolism and cerebral embolism was also noted in the article. Future studies should look into this association. If the association is confirmed patients with infective endocarditis should have investigated for both complications once they develop one. Overall this article is good and can be accepted for publication. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Shukri AlSaif Reviewer #2: Yes: Ahmed A. Elamragy Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. 12 Nov 2024 Responses to Reviewer 1 Q1. Being a retrospective review, is there any chance that some coronary embolization were not diagnosed because they did not result in clear ACS? was there any biomarker data that may shed more light on this point? R1. We thank the reviewer for this comment. All patients with infective endocarditis included in our study were routinely screened with ECG and echocardiogram during their hospitalization. So, even if we cannot exclude that coronary embolization could have passed asymptomatic, we think that the proportion of patients correctly diagnosed with coronary embolization because of signs and symptoms of ischemia significantly outweighs the number of cases not diagnosed. Moreover, the vast majority of patients with left-sided infective endocarditis were treated surgically in our center and, thus, were screened with CT or invasive coronary angiography before surgery. Myocardial enzymes were drawn in all patients treated surgically, but we have to consider that acute myocardial injury is very frequent in the post-operative course and therefore cardiac enzymes values were not specific for the diagnosis of coronary embolization. After your suggestion, we further clarified this point in the “Limitations” section of our manuscript. Q2. How systematic was the search for cerebral embolization, again could many cerebral emboli have been missed? R2. In our center all patients with left-sided infective endocarditis are routinely screened with brain CT to search for potential cerebral emboli. Therefore, we think that only a slight minority of cerebral emboli could have been missed. In patients with signs or symptoms of cerebral ischemia, repeated CT scans or MRI scans were performed, reducing the possibility of missing the diagnosis of cerebral embolization. Q3. The cases document when the coronary events occurred and I think it would be useful to include the time from presentation to the occurrence of coronary embolism in hours and also the duration of antibiotic therapy in tables 1 and 2 to see if embolic events represent delays in initiating antimicrobial therapy in relation to the diagnosis of possible infective endocarditis and try to understand better the predictors of coronary embolization. R3. We thank the reviewer for this comment. Given the fact that our center is a third-level hospital for the treatment of infective endocarditis, especially because of the presence of in-site cardiac surgery facilities, many patients were transferred from other hospitals after the diagnosis of infective endocarditis was made and when antibiotic therapy was already started. Unfortunately, data regarding the time from presentation to the occurrence of coronary embolism and the duration of antibiotic therapy cannot be retrieved from our electronic charts. We agree with the reviewer that including these data could have shed new insights on the knowledge of the predictors of coronary embolization. This could be the focus of future studies. Q4. It is not clear from the manuscript whether vegetation length was by 2D or 3D. This needs to be clarified. R4. Vegetation length was measured with 2D transesophageal echocardiography. Q5. Also I did not see any specific analysis for Coronary Embolization related to the mitral valve. R5. We thank the reviewer for this comment. In our study only patients with left-sided infective endocarditis were included. We reported in Table 1 the rates of aortic valve infective endocarditis (56.5%) and aortic valve involvement among patients with coronary embolism (62.5%). Mitral valve infective endocarditis was present in 43.5% of patients and mitral valve was involved in 37.5% of patients with coronary embolism. The association between coronary embolism and aortic or mitral valve infective endocarditis was not statistically significant (p= 0.86). Involvement of anterior or posterior mitral leaflet, presence of mitral stenosis or mitral regurgitation and grading of valve disease were not parameters included in our dataset and therefore no specific analysis in terms of the relationship with coronary embolism can be done. Q6. Is there any other echo parameter of the vegetation that can be related to cerebral or coronary embolization. R6. In our analysis we did not find a significant association between vegetation length and the risk of coronary embolization. Other echo parameter, such as vegetation mobility and site of attachment, especially in the case of the mitral valve, could be potentially associated to cerebral or coronary embolization. However, these data were not routinely collected and therefore, in our study, no statistical analysis could be performed. Q7. A limitation section need to be included. R7. We thank the reviewer for the suggestion. We added a “Limitations” section to our manuscript. Response to Reviewer 2 Thank you for this case series. I would like the authors to clarify how they decided to deal with the coronary emboli. In some cases, they left it alone and in some cases, they intervened. On what basis was the decision made? I also want to know if they analyzed the recovered embolic material and identified the causative pathogen, especially in culture negative cases. Finally, in case no.3, the authors state that the empirical antibiotics used were vancomycin and ceftriaxone, this is not a regular combination, why was it used? R. As we outlined in the discussion, there is no clear evidence of the best strategy of treatment for patients with infective endocarditis and coronary embolization. In the majority of cases presenting with acute coronary syndrome, after the diagnosis of coronary embolization thromboaspiration was performed (case #1, #4, #6). In one case (case #5), coronary artery bypass graft was preferred. In one case (case #2) no treatment was performed, because of the distal localization of the occlusion. The patient of the case #7 died before that coronary angiography could be performed. In case #3 and #8, the diagnosis of coronary embolization was made after the results of the MRI, so that an interventional procedure could not be performed. In only one case (case #6) the embolic material was retrieved, and cultural exams tested positive for the same bacteria identified with blood cultures. We recognize that routine cultural exams on embolic material could have helped in the diagnosis of patient with negative cultures (case #2). In case #3, empirical antibiotic therapy with vancomycin and ceftriaxone was started. We recognize that this combination therapy is not usual, but the patient was transferred from another center after this combination of antibiotics was started. Treatment was later shifted to ceftriaxone and gentamicin after that Gemella morbillorum was found on the valve samples. Submitted filename: Response to Reviewers.docx 15 Nov 2024 Coronary embolism in left-sided infective endocarditis. A retrospective analysis from a high-volume surgical centre and review of the literature PONE-D-24-38850R1 Dear Dr. Orlandi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ahmed Qasim Mohammed Alhatemi Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: 21 Nov 2024 PONE-D-24-38850R1 PLOS ONE Dear Dr. Orlandi, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ahmed Qasim Mohammed Alhatemi Academic Editor PLOS ONE